Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Non-cash Items (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Non-cash Items for 11 consecutive years, with $3.0 million as the latest value for Q3 2025.

  • Quarterly Non-cash Items rose 31.9% to $3.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Sep 2025, up 31.9% year-over-year, with the annual reading at $900000.0 for FY2024, 57.49% down from the prior year.
  • Non-cash Items for Q3 2025 was $3.0 million at Xtant Medical Holdings, roughly flat from $3.0 million in the prior quarter.
  • The five-year high for Non-cash Items was $3.0 million in Q2 2025, with the low at $122614.0 in Q1 2021.
  • Average Non-cash Items over 5 years is $1.5 million, with a median of $1.4 million recorded in 2023.
  • The sharpest move saw Non-cash Items soared 447.6% in 2021, then tumbled 57.49% in 2024.
  • Over 5 years, Non-cash Items stood at $649042.0 in 2021, then soared by 102.54% to $1.3 million in 2022, then soared by 61.04% to $2.1 million in 2023, then crashed by 57.49% to $900000.0 in 2024, then soared by 234.02% to $3.0 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $3.0 million, $3.0 million, and $2.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.